Krill Oil Lessens Heart Attacks in Rat Study
Rats that supplemented with Superba krill oil before an induced heart attack experienced showed signs of improved cardiovascular recovery.
Krill oil ingredients supplier Aker BioMarine (Oslo, Norway) has announced the results of a new study on rats, which found that those supplementing with the company’s Superba krill oil showed better signs of heart recovery following induced heart attacks.
A total of 53 rats were assigned to one of three treatment groups: control, krill oil 14 days after heart attack, or krill oil before and 14 days after heart attack. Compared with the control group, animals treated with krill oil before heart attack showed less dilation of the heart’s left ventricle and healthier heart and lung weights. Pretreatment with krill oil was also associated with reduced expressions of certain genes, including those relating to inflammation and ventricular stress.
“Since the beneficial effects of krill oil were dependent on initiation of treatment before induction of [heart attack], our data indicate that krill oil may have a favorable influence on the initial remodeling process after [heart attack],” said the authors of the study.
One unanswered question from the study is whether or not less dilation with krill oil could have been linked to smaller heart attacks; however, no data was available to measure heart attacks.
Funded in part by Aker BioMarine, the study has been published in the journal Lipids in Health and Disease
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
